A Study to Evaluate Symlin in Adolescent Subjects With Type 1 Diabetes Mellitus

Clinical trial NCT00313183 · COMPLETED

Trial details

NCT number: NCT00313183
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2006-04-01
Primary completion: 2007-08-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.